Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Journal of the Chinese Medical Association : JCMA
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/40813993/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266165132853250 |
|---|---|
| author | Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao |
| author_facet | Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao |
| collection | PubMed - marine biology |
| contents | Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights. Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao Humans Polycystic Ovary Syndrome Female Mitochondria Oxidative Stress Reactive Oxygen Species Insulin Resistance Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that affects women of reproductive age. It is characterized by ovulatory dysfunction, excessive levels of androgens, and the presence of multiple cysts in the ovaries. Although the exact cause of PCOS remains uncertain, recent studies have identified mitochondrial dysfunction as a key contributing factor. Mitochondria, often described as the energy centers of the cell, are essential for producing ATP, generating reactive oxygen species (ROS), and regulating cell death pathways. A growing body of evidence shows that mitochondrial dysfunction occurs in the ovaries, skeletal muscle, and adipose tissue of individuals with PCOS. This dysfunction may play a central role in the development of the disorder by increasing oxidative stress and chronic inflammation, worsening insulin resistance, and interfering with oocyte growth and quality. This review summarizes recent progress in understanding how mitochondrial dysfunction contributes to the underlying biology of PCOS. It also explores emerging treatment strategies that aim to restore mitochondrial health, such as the use of antioxidants, therapies that specifically target mitochondria, and emerging mitochondrial replacement technologies. These approaches hold promise for reducing the symptoms and long-term complications associated with PCOS. |
| format | Artículo científico |
| id | pubmed_40813993 |
| institution | PubMed |
| language | en |
| publishDate | 2025 |
| publisher | Journal of the Chinese Medical Association : JCMA |
| record_format | pubmed |
| spellingShingle | Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights. Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao Humans Polycystic Ovary Syndrome Female Mitochondria Oxidative Stress Reactive Oxygen Species Insulin Resistance Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights. Li, Chia-Jung Lin, Li-Te Lin, Pei-Hsuan Chen, Yu-Chen Lin, Po-Wen Wen, Zhi-Hong Tsui, Kuan-Hao Humans Polycystic Ovary Syndrome Female Mitochondria Oxidative Stress Reactive Oxygen Species Insulin Resistance Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that affects women of reproductive age. It is characterized by ovulatory dysfunction, excessive levels of androgens, and the presence of multiple cysts in the ovaries. Although the exact cause of PCOS remains uncertain, recent studies have identified mitochondrial dysfunction as a key contributing factor. Mitochondria, often described as the energy centers of the cell, are essential for producing ATP, generating reactive oxygen species (ROS), and regulating cell death pathways. A growing body of evidence shows that mitochondrial dysfunction occurs in the ovaries, skeletal muscle, and adipose tissue of individuals with PCOS. This dysfunction may play a central role in the development of the disorder by increasing oxidative stress and chronic inflammation, worsening insulin resistance, and interfering with oocyte growth and quality. This review summarizes recent progress in understanding how mitochondrial dysfunction contributes to the underlying biology of PCOS. It also explores emerging treatment strategies that aim to restore mitochondrial health, such as the use of antioxidants, therapies that specifically target mitochondria, and emerging mitochondrial replacement technologies. These approaches hold promise for reducing the symptoms and long-term complications associated with PCOS. |
| title | Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights. |
| topic | Humans Polycystic Ovary Syndrome Female Mitochondria Oxidative Stress Reactive Oxygen Species Insulin Resistance |
| url | https://pubmed.ncbi.nlm.nih.gov/40813993/ |